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Summary
Objective: Mitochondrial dysfunctions have been associated with apoptosis, aging and osteoarthritis (OA). Chondrocyte mitochondrial pro-
teins are attractive targets for the study of the metabolism of cartilage degradation. The copuriﬁcation of ‘‘contaminating’’ proteins has
been the major problem in all phases of mitochondrial proteome research. Therefore, we set up a procedure for the proteomic analysis of
human chondrocyte mitochondrial proteins.
Method: Four types of protein extracts were obtained from primary cultured chondrocytes isolated from healthy donors: (1) initial total chon-
drocyte extract (CE), (2) cytosol-enriched supernatant fraction (CY), (3) crude mitochondria fraction (CM), and (4) pure mitochondria fraction
(PM). Mitochondria were puriﬁed by density gradient ultracentrifugation. Mitochondrial proteins were separated by means of two-dimensional
gel electrophoresis (2-DE) and silver stained. Protein spots were then identiﬁed by mass spectrometry using MALDI-TOF/TOF technology.
Results: The best 2-DE reference map of mitochondrial proteome was constructed employing PM fraction. Thirty-nine percent of the identiﬁed
proteins were functionally distributed in the mitochondria, 14% in the endoplasmic reticulum and 36% in the cytoplasm. Examining their bi-
ological function, 22% are involved in protein targeting, 12% in signaling, 12% in glycolysis, 10% in RNA, DNA or protein synthesis, 10%
in oxidative phosphorylation and 4% in redox. The analysis of mitochondrial Mn-superoxide dismutase (SODM) revealed an age-dependent
decrease of this protein.
Conclusion: PM fraction allowed the obtention of a high quality proteomic map for the study of mitochondrial proteins in human articular chon-
drocytes. This proteomic approach may be also efﬁcient to analyze both quantitative and qualitative modulations of the mitochondrial pro-
teome in human chondrocytes during aging and pathological conditions such as OA.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Themitochondrion is one of the most complex and important
organelles found in eukaryotic cells and carries out a wide
variety of biochemical processes. Mitochondria are critical
subcellular organelles responsible for energy production
through the coupling of respiration to the generation of ade-
nine triphosphate (ATP). Mitochondria consist of four com-
ponents: an outer membrane, an inter-membrane space,
an inner membrane and amatrix. All these components func-
tion in concert to convert pyruvate and fatty acids to acetyl
CoA, which is metabolized by the citric acid cycle to produce
Nicotinamide adenine dinucleotide (NADH). High-energy
electrons from NADH are then passed to oxygen by means
of the respiratory chain in the inner membrane, producing
ATP by a chemiosmotic process. Transcription and transla-
tion take place in mitochondria, which also actively import
proteins and metabolites from the cytosol, inﬂuence pro-
grammed cell death, and respond to cellular signals, such
as oxidative stress1. In addition to their central role in energy
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2005.5metabolism, mitochondria are involved in many cellular
processes; mitochondrial dysfunctions have been associ-
ated with apoptosis, aging and a number of pathological con-
ditions, including Parkinson’s disease, diabetes mellitus,
Alzheimer’s disease and osteoarthritis (OA)1e3.
OA, which is the most common age-related cartilage and
joint pathology4, is a slowly progressive degenerative dis-
ease characterized by degradation of the matrix and cell
death, resulting in a gradual loss of articular cartilage integ-
rity5,6. The only cell type present in mature cartilage is the
chondrocyte, which is responsible for repairing the cartilage
tissue damaged by OA. Recently, the potential role of mito-
chondrial dysfunction in OA has been the subject of renewed
interest. We have demonstrated that the analysis of mito-
chondrial respiratory chain (MRC) activity in OA cells, com-
pared to normal chondrocytes, showed a signiﬁcant
decrease in complex II and III activities, aswell as a reduction
in mitochondrial membrane potential (Djm)7. Other reports
implicate a decreased mitochondrial bio-energetic reserve
as a pathogenic factor in degenerative cartilage disease8e10.
Taken together, these ﬁndings suggest that mitochondrial
proteins are an attractive target to study the metabolism of
chondrocytes and the role they play in cartilage degradation.
Most studies analyzing mitochondrial proteins in chondro-
cytes haveevaluated single proteins and havenot addressed
the totalmitochondrial proteome.With the introduction of pro-
teomics, it has become possible to simultaneously analyze
changes in multiple proteins. Currently, most proteomic07
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separate proteins, and we have recently described the total
cellular proteome of normal human chondrocytes using this
proteomic approach11. Typically, a single 2-DE gel may be
composed of protein spots numbering in the hundreds to
thousands; comparing the presence and intensity of protein
spots between gel images allows both qualitative and quan-
titative analyses. However, the copuriﬁcation of ‘‘contaminat-
ing’’ proteins has been the major problem in all subcellular
proteomic researches, including all phases of mitochondrial
proteome research12,13. It is often difﬁcult to conclude
whether these ‘‘contaminants’’ represent true endogenous
partners or artiﬁcial associations induced by cell disruption
or incomplete puriﬁcation.
The objective of this study was to set up a procedure for the
puriﬁcation of chondrocyte mitochondria with density gradient
ultracentrifugation using Percoll and the separation of its pro-
teins by 2-DE.We assessed the value of this approach for the
analysis of the mitochondrial proteins of primary normal hu-
man articular chondrocytes, and we also constructed 2-DE
databases for human chondrocytic proteins that may be use-
ful in the investigation of articular diseases. This study exhibits
the potential of combining cell culture with proteomics’ tech-
niques to analyze the human mitochondrial proteome. Be-
cause the simultaneous identiﬁcation and quantiﬁcation of
mitochondrial proteins in chondrocytes are possible with our
technique, it may be also possible to determine alterations
in mitochondrial protein levels that occur in cartilage degrada-
tion associated with the rheumatic diseases such as OA.
Materials and methods
CARTILAGE PROCUREMENT AND PROCESSING
Macroscopically normal human knee cartilage from ﬁve
donors (with ages ranging from 17 to 70 years) without his-
tory of joint disease was provided by the Tissue Bank and
the Autopsy Service at CHU Juan Canalejo. The study
was approved by the Ethics Committee of Galicia (Spain).
Once cartilage surfaces were rinsed with saline, scalpels
were used to cut parallel sections 5 mm apart, vertically
from the cartilage surface to the subchondral bone. These
cartilage strips were then cut off from this bone and the tis-
sue was incubated with trypsin at 37(C for 10 min. After re-
moving the trypsin solution, the cartilage slices were treated
for 12e16 h with type IV clostridial collagenase (2 mg/mL;
Sigma, St. Louis, MO, USA) in Dulbecco’s modiﬁed Eagle’s
medium (DMEM, Gibco BRL, Paisley, UK) with 5% fetal calf
serum (FCS, Gibco BRL) in order to release cartilage cells.
PRIMARY CULTURE OF CHONDROCYTES
Human chondrocytes were recovered and plated at high
density (4 106 per 162-cm2 ﬂask; Costar, Cambridge, MA,
USA) in DMEM supplemented with 100 units/mL penicillin,
100 mg/mL streptomycin, 1% glutamine and 10% FCS.
The cells were incubated at 37(C in a humidiﬁed gas mix-
ture containing 5% CO2 balanced with air. Chondrocytes
were used when they reached conﬂuency (2e3 weeks) in
primary culture. Cell viability was assessed by the trypan
blue dye exclusion.
PROTEIN SAMPLE PREPARATION
Chondrocytes (20e30 106 cells) were recovered from
culture ﬂasks by trypsinization and collected by centrifuga-
tion at 200 g at 4(C. After one wash in 130 mM NaCl,
5 mM KCl, 2.5 mM TriseHCl (pH 7.5) and 0.7 mM
Na2HPO4, the cells were transferred to microfuge tubesand sedimented again. For the total cell extract preparation
(fraction CE), the cell pellet was lysed and solubilized by
vortexing and a 1 h incubation with gentle agitation in
200 mL of an isoelectric focusing (IEF)-compatible lysis
buffer containing 8.4 M urea, 2.4 M thiourea, 5% CHAPS,
1% carrier ampholytes (immobilized pH gradient (IPG)
buffer pH 3e10 NL, GE Healthcare, Uppsala, Sweden),
0.4% Triton X-100, and 2 mM dithioerythritol (DTT).
For protein quantiﬁcation, 10 mL of the protein extract was
diluted 10-fold with water and precipitated for at least 1 h
with 0.02% sodium deoxycholate and 10% trichloroacetic
acid. The precipitate was washed once with two volumes
of ice-cold acetone, allowed to dry, and solubilized in alka-
line sodium dodecyl sulphate (SDS) (5% SDS, 0.1 N
NaOH). This sample (5e10 mL) was employed to quantify
total chondrocytic proteins in each lysate by the BCA tech-
nique (Pierce Perbio, Rockford, IL, USA).
ISOLATION OF CRUDE MITOCHONDRIA
For mitochondria isolation, the chondrocyte pellets were
resuspended in a swelling buffer containing 10 mM NaCl,
1.5 mM CaCl2, 10 mM TriseHCl (pH 7.5), 1 mM phenylme-
thylsulfonyl ﬂuoride (PMSF) and 10 mL/mL Protease Inhibitor
Cocktail (Sigma), and incubated for 20 min on ice. Then, 0.4
volumes of an ice-cold sucrose buffer (2.5) containing
600 mM sucrose, 150 mM mannitol, 12.5 mM TriseHCl
(pH 7.5) and 5 mM EDTA were added, and the cells were
homogenized by 30 passes through a 25-gauge needle.
The homogenates were centrifuged twice for 10 min at
1200 g at 4(C, to remove nuclei and large cellular debris.
Then, the supernatants were centrifuged at 9000 g for
15 min at 4(C, yielding a mitochondrial pellet and a cytosol-
enriched supernatant fraction (CY). The mitochondria were
carefully resuspended in 500 mL of sucrose buffer (1) de-
scribed above and centrifuged at 1200 g for 10 min at
4(C to remove further contaminants, afterwhich thesuperna-
tant was ﬁnally centrifuged at 9000 g for 15 min at 4(C to
obtain the crude mitochondrial pellet. The sample was either
further puriﬁed by density gradient ultracentrifugation (pure
mitochondria fraction (PM)), or solubilized (crude mitochon-
dria fraction (CM)) by a 1-h incubation with gentle agitation
in the urea lysis buffer previously described.
MITOCHONDRIA PURIFICATION
Crude mitochondria were thoroughly resuspended in
175 mL of a mitochondria puriﬁcation buffer (MPB) made
with 5 mM N-(2-hydroxyethyl)piperazine-N0-[2-ethanesul-
fonic acid] (HEPES) (pH 7.4), 70 mM sucrose, 210 mM
mannitol, 1 mM PMSF and 10 mL/mL Protease Inhibitor
Cocktail (Sigma). This suspension was loaded into tubes
(4 mL), onto 3.5 mL of a Percoll solution composed of
6 mM HEPES, 260 mM sucrose and 31.2% Percoll (GE
Healthcare), and centrifuged for 1 h, 15 min at 45,000 g
at 4(C in a Beckman Coulter XL ultracentrifuge equipped
with a SW 60 Ti rotor. The supernatant containing peroxi-
somes and microsomes was carefully removed and the mi-
tochondrial layer was carefully transferred to a microfuge
tube using a 1 mL pipette. The suspension was diluted
1:2 in MPB and centrifuged for 10 min at 10,000 g at
4(C to remove the Percoll. The pellet was ﬁnally solubilized
in urea lysis buffer as described above.
WESTERN BLOTTING
Western blotting was performed according to standard
procedures. Different protein extracts (30 mg) were run on
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vinylidene diﬂuoride membranes (Millipore Co, Bedford,
MA, USA). Equivalent loadings were veriﬁed by Ponceau
Red staining after transference. Membranes were blocked
in Tris-buffered saline, pH 7.4, containing 0.1% Tween-20
(TBST), and 5% nonfat dried milk for 60 min at room tem-
perature. The blots were then hybridized overnight at 4(C
with monoclonal antibodies against the a-subunit of mito-
chondrial ATPase (1:10,000, Becton-Dickinson, Bedford,
MA, USA), caspase-7 (1:1000, Becton), and mitochondrial
superoxide dismutase (SODM) (1:1000, Becton). All anti-
bodies were diluted in TBST with 2% nonfat milk. After ex-
tensive washing with TBST, immunoreactive bands were
detected by chemiluminescence using peroxidase-conju-
gated secondary antibodies and ECL detection reagents
(GE Healthcare), and digitized using a LAS 3000 instrument
(Fuji, Tokyo, Japan). Quantitative changes of protein were
evaluated with ImageQuant 5.2 software (GE Healthcare).
TWO-DIMENSIONAL GEL ELECTROPHORESIS
Chondrocyte protein extracts (100 mg) were incubated
with rehydration buffer (8.4 M urea, 2 M thiourea, 2%
CHAPS, 0.5% carrier ampholytes, 1.2% Destreak Reagent
(GE Healthcare) and 0.002% bromophenol blue) for 1 h with
gentle agitation and were then applied to 24 cm, nonlinear
pH 3e10, IPG strips (GE Healthcare) by passive overnight
rehydration. Strips were prevented from dehydration and
oxidation by covering with mineral oil (Cover Fluid, GE
Healthcare). IEF was performed for a total of 64,000 V h
at 20(C (IPGphor, GE Healthcare). Strips were collected
in tubes and stored at 80(C.
The second dimension was run after equilibration of the
strips for 15 min in 6 M urea, 50 mM TriseHCl (pH 8.8),
30% glycerol, 2% SDS and 1% DTT (reduction step), and
15 min in 6 M urea, 50 mM TriseHCl (pH 8.8), 30% glycerol,
2% SDS, 0.002% bromophenol blue and 4% iodoacetamide
(alkylation step). The strips were washed with electrophore-
sis buffer (25 mM TriseHCl, pH 8.3, 192 mM glycine, and
0.1% SDS) and ﬁxed with 0.5% agarose on top of
a 21 26 cm 10% polyacrylamide gel. The electrophoresis
was carried out according to Laemmli14 with minor modiﬁca-
tions. Brieﬂy, we used Triseglycine electrophoresis buffer
as the lower buffer (anode) and Triseglycine (2) as the
upper buffer (cathode). Samples were run at 2.5 W/gel for
the ﬁrst 30 min and then at 17 W/gel until the dye reached
the bottom of the gel.
PROTEIN STAINING
Gels were stained either with Coomassie Brilliant Blue
(CBB) or silver nitrate. CBB staining was carried out with
0.1% Brilliant Blue G-250 (Sigma) in 40% methanol and
10% acetic acid, followed by destaining in 40% methanol
and 5% acetic acid.
Silver staining was performed according to standard pro-
tocols15 with modiﬁcations. Brieﬂy, gels were ﬁxed over-
night at 4(C in 40% ethanol and 10% acetic acid, and
washed in water (3 10 min). Sensitization was carried
out for 1 min in 0.02% sodium thiosulphate (Fluka Chemie,
Buchs, Switzerland). After two consecutive washes of 1 min
each with water, the gels were impregnated with 0.2% silver
nitrate (Fluka) in 0.075% formalin for 60e90 min. Excess
silver nitrate was removed by washing with water for
a few seconds; stain development was carried out in a solu-
tion containing 3% potassium carbonate, 12.5 mg/L sodium
thiosulphate and 0.025% formalin. Once the bands or spots
on the gel reached the desired intensity, the reaction wasstopped by transferring the gels to 3% Trizma-base (Sigma)
in 10% acetic acid. After 30 min in the stop solution, gels
were scanned and dried or stored at 4(C in water.
IMAGE ACQUISITION AND DATA ANALYSIS
CBB and silver-stained gels were digitized using a densi-
tometer (ImageScanner, GE Healthcare), and analyzed with
the PDQuest 7.3.1 computer software (Bio-Rad, Hercules,
CA, USA). Using PDQuest tools, protein spots were enu-
merated, quantiﬁed and characterized with respect to their
molecular mass and isoelectric point by bilinear interpola-
tion between landmark features on each image previously
calibrated with internal 2-DE standards (Bio-Rad).
MASS SPECTROMETRY IDENTIFICATION OF PROTEIN SPOTS
The gel spots of interest were manually excised from pre-
parative gels (loaded with up to 1 mg of protein) and trans-
ferred to microfuge tubes. Samples selected for analysis
were in-gel reduced, alkylated and digested with trypsin ac-
cording to Sechi and Chait16. Brieﬂy, spots were washed
twice with water, shrunk with 100% acetonitrile and dried
in a Savant SpeedVac. Then, samples were reduced with
DTT and subsequently alkylated with iodoacetamide. Fi-
nally, samples were digested with 12.5 ng/mL sequencing-
grade trypsin (Roche Molecular Biochemicals, IN, USA)
for at least 6 h at 37(C. After digestion, the supernatant
was collected and 1 mL was spotted onto a MALDI target
plate (98 2 spot Teﬂon-coated plates) and allowed to
air-dry at room temperature. Then, a-cyano-4-hydroxy-
trans-cinnamic acid matrix (Sigma) in 50% acetonitrile
(0.4 mL of a 3 mg/mL solution) was added to the dried
peptide digest spots and again allowed to air-dry. MALDI-
TOF-MS analyses were performed in a Voyager-DE
STR instrument (PerSeptive Biosystems, Framingham,
MA, USA). All mass spectra were internally and externally
calibrated using autoproteolytic trypsin fragments and
a standard peptide mixture (Sigma), respectively. MS/MS
sequencing analyses were carried out using the MALDI-
TOF/TOF mass spectrometer 4700 Proteomics Analyzer
(Applied Biosystems, Framingham, MA, USA).
The monoisotopic peptide mass ﬁngerprinting (PMF) data
obtained from MALDI-TOF were used to search for protein
candidates using MS-Fit (http://prospector.ucsf.edu), Pro-
found (http://www.prowl.rockefeller.edu) and Mascot (http://
www.matrixscience.com) software programs. Searches
were performed against SWISS-PROT/TrEMBL (http://
www.expasy.ch/sprot) and NCBI (http://www.ncbi.nlm.nih.gov)
databases. Identiﬁcations were accepted as positive when
at least ﬁve matching peptides and at least 20% of the
peptide coverage of the theoretical sequences matched
within a mass accuracy of 50 or 25 ppm with internal cal-
ibration. Tryptic autolytic fragments and other contamina-
tions were removed from the dataset used for the
database search. In the MALDI-TOF/TOF analysis, the
aminoacidic sequence tag obtained from each peptide
fragmentation was used for protein identiﬁcation in
searches against the SWISS-PROT/TrEMBL database.
Results
ISOLATION AND PURIFICATION OF CHONDROCYTE
MITOCHONDRIA
A mitochondria puriﬁcation procedure was developed
for human articular chondrocytes. This procedure consists
of two steps: the obtention of a mitochondria-enriched
fraction (CM) by means of differential centrifugation, and
510 C. Ruiz-Romero et al.: Mitochondrial proteomics of human normal chondrocytesFig. 1. The purity of Percoll-puriﬁed mitochondria (PM) compared to the initial total chondrocytes extract (CE) or cytosol-enriched fraction (CY);
crude mitochondria fraction (CM) or puriﬁed mitochondria fraction (PM) was assessed. Equivalent loads (30 mg of each sample) were sepa-
rated by 10% SDS-PAGE gels and (A) silver stained, or (B) subjected to Western blot analyses with antibodies directed against proteins from
various cellular locations. The upper panel depicts the enrichment of the component of the electron transport chain ATPase a in the PM,
whereas the bottom panel depicts the absence of the nonmitochondrial protein caspase-7 in this fraction. These Western blot analyses
demonstrate a good enrichment of mitochondria following mitochondria puriﬁcation.
Fig. 2. Representative 2-DE gels (nonlinear pH 3e10, 10% acrylamide, silver stained) of different cellular extracts obtained from chondrocytes.
CE: total cell extract; CY: cytosol-enriched fraction; CM: crude mitochondria fraction; and PM: puriﬁed mitochondria fraction.
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ent ultracentrifugation (45,000 g) using Percoll (see Mate-
rials and methods). We prepared protein extracts of the
different cellular extracts obtained from chondrocytes in the
puriﬁcation process: CE, CY, CM and PM. These proteins
were then separated by SDS-polyacrylamide gel electropho-
resis (PAGE) and visualized by silver staining [Fig. 1(A)]. The
purity of mitochondria was assessed by immunoblotting with
antibodies against known proteins from mitochondria
(ATPase a, a component of the electron transport chain)
and cytosol (caspase-7). As shown in the Western blot illus-
trated in Fig. 1(B), mitochondrial ATPase a was remarkably
increased in the PM fraction, whereas this fraction lackedany detectable contamination of cytosolic proteins such as
caspase-7.
2-DE CHARACTERIZATION OF CHONDROCYTE
MITOCHONDRIA
These results were further validated by 2-DE analysis. Fig-
ure 2 illustrates the proteomic bidimensional maps of the dif-
ferent protein extracts. A general view of these maps reveals
some important differences in the proteomes. More detailed
qualitative and quantitative analyses of the bidimensional
gels, as shown in Fig. 3, point out several modiﬁcations of
proteins in the different subfractions. Some of these proteinsFig. 3. Quantity modiﬁcations of characteristic proteins in the different cellular subfractions obtained from chondrocytes. CE: total cell extract;
CY: cytosol-enriched fraction; CM: crude mitochondria fraction; and PM: puriﬁed mitochondria fraction. Enlarged squares marked on the 2-DE
gels are shown at the bottom. SODM, mitochondrial superoxide dismutase; PEBP, phosphatidylethanolamine-binding protein; CRAB, chain B
of a-crystallin; ANX2, annexin 2; G3P2, glyceraldehyde-3-phosphate dehydrogenase; PDI, protein disulﬁde isomerase; VIME, vimentin, and
ATPb, b subunit of ATPase.
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basis of peptide mass matching17 after in-gel digestion with
trypsin. The identiﬁcations revealed that mitochondrial
proteins such as Mn-SODM and ATP synthase b chain
(ATPb) are increased in the mitochondrial fractions (CM
and PM), compared to CE and CY fractions [Fig. 3(A,C)].
It is also relevant that the relative quantity of both mitochon-
drial proteins, SODM and ATPb, is higher in the PM than in
the CM one. On the other hand, some characteristic cyto-
plasmic proteins such as chain B of a-crystallin (CRAB),
glyceraldehyde-3-phosphate dehydrogenase (G3P2) and
vimentin (VIME) were more abundant in the CE and CY frac-
tions than in the CM and PM fractions, as expected
[Fig. 3(A,B,C)].
2-DE REFERENCE MAP OF MITOCHONDRIAL PROTEINS FROM
HUMAN NORMAL ARTICULAR CHONDROCYTES
The chondrocyte mitochondria puriﬁcation procedure was
employed for the generation of a bidimensional reference
map and database of human chondrocytic mitochondrialproteins. Chondrocyte mitochondria from ﬁve different
healthy donors were disrupted in a 2-DE-compatible lysis
buffer that improves the solubilization of membrane-associ-
ated proteins18. Under these conditions, the yield of mito-
chondrial protein extraction was about 150e175 mg of
protein per ten million chondrocytes. We made duplicate 2-
DE gels from each donor in order to verify the reproducibility
of the protein pattern (data not shown). Figure 4 illustrates
the proteomic characterization carried out on this mitochon-
drial pattern.
We identiﬁed a total of 66 unambiguous proteins from 90
excised spots (73%) by means of PMF. The spots were ex-
cised from each of three 2-DE gels carrying proteins from
the PM. Additionally, six samples that could not be recog-
nized with the information available in the PMF were identi-
ﬁed by tandem mass spectrometry using MALDI-TOF/TOF
technology. In total, our analysis leads to the identiﬁcation
of 72 spots that represent 49 different proteins (Table I).
All the proteins identiﬁed in this work are listed in Table I,
and indicated by name on the 2-DE reference map shown in
Fig. 4. Numbers of peptide matches and percentages ofFig. 4. 2-DE map of mitochondrial proteins from human articular chondrocytes (nonlinear pH 3e10, 10% acrylamide SDS-PAGE, silver stain-
ing). The 72 mapped and identiﬁed spots are annotated by their protein names according to the SWISS-PROT database. For these abbre-
viations see Table I.
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Functional classification of proteins isolated from 2-DE gels of mitochondrial cell extracts from human normal chondrocytes and identified by
mass spectrometry
Spot
name*
Description Acces.
No.*
Mr prey (kDa) pI prey No. of
matched
peptidesz
Seq.
cov.x (%)
Subcellular
locationk
Metabolism
Lipid metabolism
ECHA Long-chain enoyl -CoA hydratase P40939 83.7 9.16 13 15 Mit
GFYIYQEGVK{
HCD Short chain 3-hydroxyacyl-CoA
dehydrogenase, mitochondrial
Q16836 34.3 8.88 14 26 Mit
Carbohydrate
IDH3 Isocitrate dehydrogenase subunit
beta mitochondrial precursor
O43837 42.2 8.64 20 45 Mit
Nucleotide
TY3M Thymidine phosphorylase precursor,
(Gliostatin, Endothelial cell growth factor 1)
P19971 50.3 5.37 10 21 Mit
Aminoacid
3HIDH 3-hydroxyisobutyrate dehydrogenase,
mitochondrial
P31937 35.7 8.38 MGAVFMDAP
VSGGVGAAR{
Mit
PGDH Phosphoglycerate dehydrogenase Q5SZU1 57.3 6.29 14 26 Cyt
RNA/DNA/Protein synthesis
RLA0 60S Acidic ribosomal protein P0 P05388 34.4 5.42 10 42 Cyt
NNMT Nicotinamide N-metyltransferase P40261 30.0 5.56 14 36 Cyt
P4HA1 Procollagen precursor P13674 61.2 5.70 12 24 ER
PDA3 Protein disulﬁde-isomerase
ER60 precursor (GRP58)
P30101 56.8 5.98 23 37 ER
22 36
PDI Protein disulﬁde-isomerase precursor P07237 57.1 4.76 14 37 ER
Glycolysis
ALFA Fructose-bisphosphate aldolase A P04075 39.3 8.39 13 43 Cyt
ENOA Alpha enolase
(2-phosphopyruvate hydratase)
P06733 47.4 6.99 7 21 Cyt
G3P2 Glyceraldehyde 3-phosphate
dehydrogenase
P04406 35.9 8.26 19 58 Cyt
12 38
KPYM Pyruvate kinase M1 isozyme P14618 58.3 7.20 10 17 Cyt
12 20
PGK1 Phosphoglycerate kinase 1 P00558 44.6 8.30 16 57 Cyt
TPIS Triosephophate isomerase P60174 26.8 6.51 16 63 Cyt
OXPHOS
ATPA Similar to ATP synthase alpha subunit P25705 59.8 9.16 10 23 Mit
12 24
ATPB ATP synthase beta chain P06576 56.6 5.26 19 49 Mit
22 48
ATPQ ATP synthase D chain O75947 18.4 5.22 SWNETLTSR{ Mit
ATPA1 ATP synthase mitochondrial F1 complex Q96FB4 59.9 9.07 6 12 Mit
UQCR1 Ubiquinol-cytochrome-c-reductase
complex core protein I
P31930 52.6 5.94 9 15 Mit
Proteases
CATD Cathepsin D precursor P07339 44.6 6.10 19 34 Lys
18 35
15 26
Protein targeting
CALU Calumenin precursor (Crocalbin) O43852 37.1 4.47 10 30 ER
CRAB Alpha crystallin chain B (Hsp beta-5) P02511 20.1 6.76 12 54 Cyt, Mem
CRTC Calreticulin (grp60) P27797 48.3 4.29 17 47 ER, Cyt
ENPL Endoplasmin precursor (GRP94) P14625 90.3 4.73 26 28 ER
20 25
GRP75 75 kDa Glucose-related protein P38646 73.7 5.87 20 26 Mit
18 22
GRP78 78 kDa Glucose-related protein P11021 72.4 5.07 24 43 ER
HS7C Heat shock cognate 71 kDa protein P11142 70.9 5.37 15 23 Cyt/Nuc
HSP60 60 kDa heat shock protein
mitochondrial precursor
P10809 61.2 5.70 18 32 Mit
17 33
HSPA8 HSPA8 protein (fragment) belongs to
the heat shock protein 70 family
Q96IS6 64.7 5.36 13 19 Cyt
continued on next page
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Spot
name*
Description Acces.
No.*
Mr prey (kDa) pI prey No. of
matched
peptidesz
Seq.
cov.x (%)
Subcellular
locationk
HSPB6 Heat shock protein beta-6 O14558 17.1 5.95 VVGEHVEV
HAR{
Cyt
PHB Prohibitin (PHB, p32) P35232 29.8 5.57 9 46 Mit
Structural
ACTB Beta actin P60709 41.7 5.29 20 59 Cyt
22 58
19 48
10 35
ACTN1 Actinin alpha 1 fragment P12814 103.7 5.25 21 26 Cyt
TBA Tubulin alpha chain Q71U36 50.5 4.96 20 44 Cyt
21 46
TBB Tubulin beta polypeptide Q9H4B7 50.2 4.78 19 42 Cyt
VIME Vimentin (fragment) P08670 53.6 5.09 15 37 Cyt
Redox
SODM Superoxide dismutase
(Mn) mitochondrial
P04179 22.3 6.86 10 65 Mit
12 66
23 51
PRDX3 Peroxiredoxin 3 (mitochondrial
thioredoxin-dependent peroxide
reductase)
P30048 28.1 7.11 DYGVLLEG
SGLALR{
Mit
Signaling
ANX1 Annexin I P04083 38.9 6.57 19 50 Mem
ANX2 Annexin II P07355 38.7 7.56 15 43 Mem, Mit
19 46
23 52
5 16
15 42
ANX4 Annexin IV P09525 36.0 5.85 27 54 Mem
ANX5 Annexin V P08758 35.8 4.94 24 78 Mem, Mit
32 54
ANX6 Annexin VI P08133 76.0 5.42 41 59 Mem
LEG3 Galectin 3 P17931 26.1 8.60 11 32 Mit
Unknown
IMMT Mitochondrial inner
membrane protein
Q16891 79.8 5.71 26 34 Mit
27 30
DKFZp Hypothetical protein
DKFZp451J0218
Q86T83 154 5.92 IMGIPEEEQMGLLR{ Cyt?
*Protein name and accession number according to SWISS-PROT and TrEMBL databases.
yPredicted Mr and pI according to protein sequence and SWISS-2DPAGE database.
zNumber of peptide masses matching the top hit from MS-Fit PMF.
xAminoacidic sequence coverage for the identiﬁed proteins.
kAccording to database information (SWISS-PROT/TrEMBL) and bioinformatics prediction (WolfPSORT, http://wolfpsort.seq.cbrc.jp). Mit:
mitochondria; ER: endoplasmic reticulum; Cyt: cytoplasmic; Mem: plasma membrane; and Lys: lysosomal.
{Sequence tag identiﬁed by tandem mass spectrometry using MALDI-TOF/TOF MS.sequence covered in the PMF (see Materials and methods)
are annotated in Table I. Experimental molecular weight
(Mr) and isoelectric point (pI ) values are in general agree-
ment with the corresponding theoretical ones for the major-
ity of the proteins (data not shown), except for the cases in
which protein fragments have been identiﬁed.
PROTEIN ROLE AND SUBCELLULAR LOCATION ASSIGNMENT
The identiﬁed proteins were also classiﬁed into different
groups according to their biological function or cellular
role. To accomplish the classiﬁcation, we employed func-
tional catalogues from SWISS-PROT and TIGR databases.
A graphical representation of the functional categories of
identiﬁed proteins is shown in Fig. 5. A signiﬁcant proportion
of proteins are involved in protein targeting (22%), signaling(12%), glycolysis (12%), RNA/DNA/protein synthesis
(10%), oxidative phosphorylation (OXPHOS) (10%), metab-
olism (12%), proteases (2%) and redox (4%).
We also examined the subcellular location of the identi-
ﬁed proteins according to database information and predic-
tion by bioinformatics tools (http:wolfpsort.seq.cbrc.jp) (see
Table I). We found that 39% of them indeed exert its func-
tion in the mitochondria, whereas others are predicted to
be located in other subcellular compartments such as the
endoplasmic reticulum (14%) or the cytoplasm (36%).
EXPRESSION ANALYSIS OF MITOCHONDRIAL SODM
As it was previously mentioned, several rheumatic dis-
eases are associated with aging, and knowledge about ag-
ing processes can be gained by recognizing changes in
515Osteoarthritis and Cartilage Vol. 14, No. 6Fig. 5. Functional distribution of the mitochondrial proteins identiﬁed by 2-DE and mass spectrometry in normal human articular chondrocytes.
Assignments were made on the basis of classiﬁcations provided in the MITOP database.mitochondrial protein expression. We validated the useful-
ness of our proteomic approach to study these protein
changes with the analysis of age-dependent modiﬁcations
in a mitochondrial protein identiﬁed in our 2-DE maps, the
Mn-SODM. Figure 6(A) shows the 2-DE maps of mitochon-
drial fractions from normal cartilage of young (17 years old)
to old (70 years old) donors. These maps exhibit the signiﬁ-
cant age-dependent decrease of SODM levels, whereas the
glycolysis protein triosephosphate isomerase (TPIS) re-
mains similar in all donors independent of age. These results
were veriﬁed by Western blotting of the same protein sam-
ples with monoclonal antibodies against SODM [Fig. 6(B)].
Quantity analysis of the blots with ImageQuant 5.2 software
revealed that the amount of SODM in the chondrocyte
mitochondrial protein extracts of the 36-, 58- and 70-
year-old donors is reduced by 24%, 34% and 47%, respec-
tively, when compared to those of the 17-year-old donor.
Discussion
In this work, we have developed a simple and powerful
strategy for the efﬁcient identiﬁcation and analysis of chon-
drocyte mitochondrial proteins with a wide range of bio-
chemical characteristics. The quality of a subcellular
proteome, such as that of a mitochondrion, is largely depen-
dent on its purity13,19. Thus, we ﬁrst optimized the puriﬁca-
tion procedure that allowed the isolation of high-purity
mitochondria from chondrocytes. The Western blot analy-
ses with antibodies against known proteins from mitochon-
dria and cytosol demonstrate the convenience of using our
two-step puriﬁcation procedure in order to attain a high en-
richment of mitochondrial proteins in the protein samples.
Cartilages used for chondrocyte isolation proceed from
donors that covered a broad range of ages (17e70 yearsof age). We present in this work a mitochondrial reference
map that is representative of all the donors with minor differ-
ences, and carry out a proteomic characterization based on
this reproducible pattern. The efﬁcient and powerful protein
separation that can be achieved with 2-DE technology was
optimized by the use of a broad range of IPG strips (nonlin-
ear pH 3e10) and large-sized gels (21 26 cm), leading to
the detection of more than 1200 silver-stained proteins on
each analytical gel loaded with 100 mg of mitochondrial pro-
tein lysate.
The proteomic characterization of chondrocyte mitochon-
dria carried out by this approach led to the identiﬁcation of
49 different proteins. Interestingly, two of them display un-
known cellular functions. One of them is the mitochondrial
inner membrane protein mitoﬁlin (IMMT). Mitoﬁlin is en-
riched in the narrow space between the inner boundary
and the outer membranes where it forms a homotypic inter-
action and assembles into a large multimeric protein com-
plex. Recently, it was proposed that mitoﬁlin is a critical
organizer of the mitochondrial cristae morphology and,
thus, indispensable for normal mitochondrial function20.
Many proteins identiﬁed in this work have a reported
mitochondrial location. However, there are a number of pro-
teins detected in our puriﬁed mitochondrial preparations
that have been described thus far in other subcellular com-
partments. Some of them are located in the endoplasmic
reticulum (14%) and another 36% of them have been previ-
ously characterized as cytoplasmic (see Table I). A similar
proportion of mitochondrial and cytoplasmic proteins has
been previously quantiﬁed using a sucrose gradient
method13. We suggest, as other authors have proposed,
that the intimate association between mitochondria and
the cytoplasm or endoplasmic reticulum may explain the
presence of these proteins in our preparation13. Thus, this
516 C. Ruiz-Romero et al.: Mitochondrial proteomics of human normal chondrocytesFig. 6. Modiﬁcations in the quantity of the mitochondrial protein SODM in chondrocytes from cartilage donors of different ages. (A) Age-related
decrease of SODM by 2-DE analysis. Enlarged squares marked on the 2-DE gels are shown at the bottom, each annotated with the sex and
age of the corresponding donor. SODM: mitochondrial superoxide dismutase. TPIS: triosephosphate isomerase. (B) Age-related decrease of
SODM revealed by Western blot analysis. Thirty micrograms of protein from each sample used in (A) were separated and immunoblotted with
antibodies against SODM.may indicate a functional association of mitochondria with
other cellular compartments rather than contamination. Ac-
cording to this hypothesis is the fact that one of the proteins
identiﬁed in our mitochondrial fraction, Galectin 3 (LEG3),
was previously described as nuclear by sequence analysis,
cytoplasmic in adenomas and carcinomas, and as a se-
creted protein in other reports. However, recent studies
demonstrate that this protein is also enriched inmitochondria, where it acts preventing mitochondrial dam-
age and cytochrome c release21.
Proteins from the annexin family e mainly Annexins 2
(ANX2) and 5 (ANX5) e were remarkably abundant in the
mitochondrial fractions. The annexins are a family of
structurally-related proteins that bind phospholipids in a cal-
cium-dependent manner. Although the precise functions of
annexins are unknown, there is an accumulating set of data
517Osteoarthritis and Cartilage Vol. 14, No. 6arguing for a role for some of them in vesicular transport
and, speciﬁcally, in membraneemembrane or membranee
cytoskeletal interactions during these processes. Annexin
2 has been shown to form Ca2þ channels in phospholipid
bilayers, liposomes, and also in matrix vesicles, enabling
Ca2þ inﬂux into these particles as a possible initial step
for the formation of the ﬁrst mineral phase within the ves-
icle lumen22. Annexins have been previously detected on
early endosomes, on late endocytic organelles and mito-
chondria23. In chondrocytes, annexin-mediated Ca2þ in-
ﬂux into growth plate chondrocytes is a positive
regulator of terminal differentiation, mineralization, and ap-
optosis24. In all these events, mitochondria also play an
important role; our results support the concept that the
association of cytoskeleton proteins with mitochondria is
likely to be physiologically relevant.
As it was previously mentioned, several rheumatic dis-
eases are associated with aging, and knowledge about ag-
ing processes can be gained by recognizing changes in
mitochondrial protein expression. Reactive oxygen species
(ROS) are implicated in both cartilage aging and the patho-
genesis of OA3,25. The mitochondrial Mn-SODM is an en-
zyme that protects cells from ROS damage because it
dismutates the superoxide anion. In human chondrocytes,
there is a correlation between aging and a decrease in
the activity of SODM26. Furthermore, it has been described
that chondrocytes isolated from OA cartilage contain lower
levels of SODM than those isolated from normal carti-
lages26,27. Our proteomic approach supports these hypoth-
eses, and we veriﬁed them by means of Western blotting.
Thus, our results demonstrate that from all protein frac-
tions employed to carry out a mitochondrial proteomic
map of chondrocytes, the PM fraction permitted to obtain
the highest quality map. We show that proteomic analysis
by 2-DE could be effectively applied to the assessment of
the age status of protein expression, and thereby provides
valuable information on age-related changes of the mito-
chondrial chondrocytic proteome. Characterization of a bidi-
mensional reference map of these proteins, with the
identiﬁcation of 72 of them, may be a useful tool for future
differential expression studies. This proteomic approach
may also be efﬁcient to study both quantitative and qualita-
tive modulations of the mitochondrial proteome in human
chondrocytes during aging and diverse pathological condi-
tions such as OA.
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